M. Schmidt

The Lancet · 2002–2021

A researcher in the Science corpus: 16 papers; trusts 0 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Who trusts M. Schmidt

1. V. Basevi (in Obstetrics and Gynecology)
2. E. Ford (in Endocrinology, Diabetes and Metabolism)

Papers from M. Schmidt's perspective

Ordered by how strongly the researchers M. Schmidt trusts endorse each paper. Same corpus, a different order for every researcher.

1. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. (Journal of the American Medical Association (JAMA))
2. Quantifying heterogeneity in a meta‐analysis (Statistics in Medicine)
3. Hyperglycemia and Adverse Pregnancy Outcomes
4. GRADE guidelines: 2. Framing the question and deciding on important outcomes. (Journal of Clinical Epidemiology)
5. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. (Journal of Clinical Epidemiology)
6. A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes (New England Journal of Medicine)
7. Cardiovascular morbidity and mortality associated with the metabolic syndrome. (Diabetes Care)
8. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ (Proceedings of the Nutrition Society)
9. Gestational diabetes: the consequences of not treating. (American Journal of Obstetrics and Gynecology)
10. Macrosomic births in the united states: determinants, outcomes, and proposed grades of risk. (American Journal of Obstetrics and Gynecology)

Their papers

• Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019 (2021) — 757 citations
• The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2020) — 1,072 citations
• The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. (2020) — 616 citations
• Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) — 2,198 citations
• Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) — 4,276 citations
• Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) — 632 citations
• Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) — 4,590 citations
• Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. (2016) — 5,345 citations
• Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015 (2016) — 1,771 citations
• Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. (2014) — 816 citations
• Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria (2012) — 596 citations
• Chronic non-communicable diseases in Brazil: burden and current challenges. (2011) — 1,217 citations
• International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy (2010) — 4,779 citations
• The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. (2005) — 1,024 citations
• Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. (2003) — 1,049 citations
• Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. (2002) — 8,521 citations